Mark Flannagan
Mark Flannagan is chief executive of Beating Bowel Cancer.
- Comment
The age of information awaits the NHS and its patients
The benefits of good data cannot be underestimated.
Mark Flannagan is chief executive of Beating Bowel Cancer.
2012-05-31T06:00:00
The benefits of good data cannot be underestimated.
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud